Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002240280 | SCV001665745 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-04-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038608 | SCV005032297 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001701168 | SCV001926751 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701168 | SCV001965976 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003965915 | SCV004784678 | likely benign | COL5A1-related disorder | 2023-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |